Genetic Screening in Europe

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift


Genetic screening has been defined as any kind of test performed systematically for the early detection or exclusion of a genetic disease, genetic predisposition or resistance to a disease, or to determine whether a person carries a gene variant that may produce disease in his or her offspring. In comparison to 'genetic testing', the term 'genetic screening' should be reserved for the explicit and systematic application of a diagnostic genetic test across a whole population of asymptomatic people (population screening) or a subset of a population such as pregnant women (prenatal/antenatal screening) or newborn infants (neonatal screening). This survey intends to present the current (2006-2008) status of genetic screening and the organization of genetic screening programmes in selected European countries as a background for future attempts to harmonize standards and procedures of genetic screening, an explicit aim of the European Network of Excellence, EuroGentest ( Our report builds on the first comprehensive assessment of genetic screening programmes in Germany by the European Society of Human Genetics, starting with a workshop of experts in 1999, the production of background documentation in 2000, and a final report in 2003. Copyright (C) 2010 S. Karger AG, Basel


Enheter & grupper

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Medicinsk genetik


Sidor (från-till)524-537
TidskriftPublic Health Genomics
Utgåva nummer7-8
StatusPublished - 2010
Peer review utfördJa